Genomics & Omics Analysis - software & AI news

Daily news on software, AI, and companies shaping genomics & omics analysis.

Showing 121 results
A flat illustration of a DNA strand and a blood droplet, symbolizing cancer detection technology.

Jul 7, 2026

Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology

Strand Life Sciences, part of Reliance Industries, has secured an Indian patent for its innovative blood-based cancer detection technology, leveraging cell-free DNA analysis.The patented platform integrates advanced genome sequencing, stringent quality control measures, and machine learning to analyze methylation patterns in cfDNA. This method is designed to identify cancer early and determine its tissue origin from a blood sample, addressing a critical need for sensitive diagnostics. The abilit
A DNA strand on a table in a dimly lit lab with research notes in the background.

Jul 4, 2026

DoH signs agreements to reinforce intelligent life sciences through genomics, AI, research, and healthcare investment

Abu Dhabi's recent strategic mission to the US has solidified its role as a leader in intelligent life sciences, marked by 22 new partnerships aimed at enhancing collaboration in genomics, AI, and advanced therapeutics.The mission, which included over 40 representatives from various sectors, spanned key cities like San Francisco and Los Angeles, facilitating more than 30 strategic meetings with global healthcare organizations. This initiative highlights Abu Dhabi's commitment to creating a compr
A sample vial in a dimly lit lab, reflecting FTIR spectra.

Jul 4, 2026

IIT-Mandi develops AI framework to speed up molecular analysis, biomedical diagnostics

Researchers at IIT-Mandi have unveiled BioFASTNet, an innovative AI framework designed to enhance molecular analysis and biomedical diagnostics by streamlining the interpretation of Fourier Transform Infrared (FTIR) spectra.This advanced framework aims to eliminate the complexities associated with traditional FTIR analysis, which often requires extensive preprocessing and specialized expertise. By enabling quicker and more accurate results, BioFASTNet could significantly advance real-time clinic
A minimalist representation of a diagnostic test strip and sample droplet.

Jul 1, 2026

Going Local: The New APAC Diagnostics Playbook

The Asia-Pacific (APAC) region is rapidly evolving into a significant diagnostics hub, moving beyond dominance by a few large markets to a more diversified landscape. This transformation is driven by advancements in genomics, molecular diagnostics, artificial intelligence (AI), and precision medicine, reflecting the unique healthcare needs and innovation capabilities of each country.The diagnostics market in APAC is projected to exceed $38 billion, with key players including China, Japan, South
An epigenetic sample under a microscope in a dimly lit lab

Jun 29, 2026

PredictMe secures SEK 5M to advance AI-driven diagnostics

PredictMe, a Swedish HealthTech startup, has successfully raised SEK 5 million in seed funding to enhance its AI-driven platform aimed at early disease detection through epigenetic analysis.Based in Linköping, PredictMe's recent funding round, led by entrepreneur Linus Gunnarson, will facilitate the expansion of its innovative artificial intelligence system. This platform is designed to identify diseases prior to the onset of clinical symptoms, marking a significant advancement in preventive med
Minimalist illustration of a protein structure and DNA helix

Jun 29, 2026

NVIDIA adds BioNeMo toolkit for life sciences AI agents

NVIDIA has launched the BioNeMo Agent Toolkit, designed to enhance AI workflows within the life sciences sector. This toolkit aims to facilitate various processes, including protein design, genomic analysis, and medical imaging analysis.The BioNeMo Agent Toolkit encompasses a range of specialized tools and libraries developed over a decade, enabling researchers and labs to analyze scientific data more effectively. By integrating with existing biopharma systems and general-purpose AI agents, the
A petri dish with DNA methylation biomarkers in a dimly lit lab setting.

Jun 24, 2026

Hyderabad Student Builds AI Model for Early Lung Cancer Detection Using DNA Biomarkers

A student from Hyderabad has made strides in lung cancer detection by developing an AI model that utilizes DNA methylation biomarkers. This innovative approach aims to enhance early diagnosis and non-invasive screening methods.In a recent study titled “DNA Methylation Biomarkers for Lung Cancer Detection: An AI-Driven Approach Using EGFR, PD-L1, SHOX2, RASSF1A and PTGER4,” Class XII student Ansh Kumar analyzed over 7,000 patient samples. The model integrates multi-gene biomarker profiling with m
Silhouette of a coronary artery with a heart shape

Jun 23, 2026

Cardio Diagnostics Holdings (NASDAQ: CDIO) Targets a $393B Heart Disease Problem with Epigenetics and AI

Cardio Diagnostics Holdings is addressing the escalating heart disease crisis, projected to escalate from $393 billion in healthcare costs in 2020 to $1.4 trillion by 2050, by leveraging epigenetics and artificial intelligence for early detection.The company aims to improve the diagnosis of coronary heart disease, a condition that has long been the leading cause of death in the U.S., claiming over 940,000 lives in 2022 alone. Traditional diagnostic methods often miss critical cases, but Cardio D
A minimalist illustration of a cancer cell with a diagnostic test overlay in a dark palette.

Jun 23, 2026

Qlucore Receives EUR 0.5 Million EU Payment

Qlucore has successfully secured a third payment of approximately EUR 0.5 million as part of a larger EUR 2.5 million EU grant aimed at advancing cancer diagnostic solutions.The funding is intended to enhance the development of clinical diagnostics specifically for acute myeloid leukemia (AML) and bladder cancer. This initiative reflects a growing commitment to precision medicine, leveraging AI-driven software to improve diagnostic accuracy and healthcare efficiency.Qlucore's advancements includ
A liquid biopsy sample in a test tube on a laboratory countertop during blue hour.

Jun 22, 2026

Is Twist Bioscience’s (TWST) New ATM Program Quietly Reframing Its AI Genomics Investment Story?

Twist Bioscience is making strategic moves to enhance its investment narrative through a new financing program aimed at bolstering its role in AI-driven genomics.In June 2026, Twist Bioscience initiated an extensive shelf registration that includes a $200 million at-the-market equity offering. This move not only provides the company with increased financial flexibility but also positions it prominently in the liquid biopsy and AI genomics sectors. The interest from Osterweis Opportunity Fund fur
A flat illustration of a blood cell representing cancer diagnostics.

Jun 17, 2026

Qlucore Receives Approval for EUR 0.5 Million EU Payment

Qlucore has secured a third installment of approximately EUR 0.5 million from a total EU grant of EUR 2.5 million, aimed at enhancing cancer diagnostic solutions.The funding is part of a three-year initiative focused on developing clinical diagnostic software for acute myeloid leukemia (AML) and bladder cancer. With the recent approval, Qlucore is set to continue its progress in creating CE-marked software intended for clinical laboratories, which will also aid in developing companion diagnostic
A minimalist illustration of a blood droplet and heart silhouette on a dark background.

Jun 15, 2026

Cardio Diagnostics Leverages AI and Genetics to Transform Cardiovascular Risk Detection

Cardio Diagnostics Holdings is advancing cardiovascular disease detection by integrating AI with genetic and epigenetic biomarkers, aiming for more effective early risk identification and personalized interventions.The company is developing a range of solutions that utilize artificial intelligence alongside genetic and epigenetic data to enhance the prevention, detection, and management of cardiovascular diseases. Their platform focuses on providing personalized insights through blood-based test